Compare ClearPoint Neuro Inc (CLPT) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Global X NASDAQ 100 Covered Call ETF — how do they compare? ClearPoint Neuro Inc trades at $15.22 (market cap $454.21M), while Global X NASDAQ 100 Covered Call ETF trades at $18.19. The key difference: Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | QYLD | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $29.60 | $18.52 |
52-Week Low | $8.66 | $16.46 |
Enterprise Value | $488.79M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.
The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.
QYLD trades at $18.18, up 0.14% on the day, with a bullish technical signal from moving averages but bearish oscillators. The ETF offers a high distribution yield near 12% through covered call strategies on the Nasdaq-100, though historical data shows it has underperformed the index in strong bull markets. Recent dividends include $0.18 and $0.19 payouts in mid-2026.
Outlook is mixed: QYLD provides substantial income for risk-averse investors in sideways markets, but caps upside potential. Key risks include erosion of net asset value during rallies and competition from lower-fee alternatives. Analyst sentiment is divided, with some upgrades highlighting yield appeal amid volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
